Karolinska University Hospital welcomed as new site in expansion of Horizon 2020 project DeteCTCs

Stockholm, Sweden – April 18, 2023 – iCellate is excited to announce the expansion of the Horizon 2020 project, DeteCTCs, to Sweden with the addition of clinical site Karolinska University Hospital led by principal investigator Matthias Löhr. The DeteCTCs project is led in collaboration with QIAGEN and University Medical Center Schleswig-Holstein.iCellate, QIAGEN, and University Medical Center Schleswig-Holstein were awarded 2.4 million euro from European Funding Agency, Horizon 2020 in February 2021. The ongoing project aims to make iCellate’s CTC platform CellMate® available to cancer